Strength: 500 mg/100 mL, 1 g/100 mL
Form: Intravenous (IV)
Reference Brands: Flagyl(US), Metronidazol-Darnytsia (Ukraine)
Strength: 125 mg/5 mL, 250 mg/5 mL, 375 mg/5 mL
Form: Suspension
Reference Brands: Flagyl(US), Metrogyl Suspension (India), Metrowell (India)
Strength: 250 mg, 500 mg
Form: Oral Tablets and Capsules
Reference Brands: Flagyl(US), Metron (India)
Strength: 500 mg/250 mL, 1000 mg/250 mL
Reference Brands: Zithromax, Z-Pak(US); Zidimax(EU), Aziwok IV (India)
Strength: 250 mg, 500 mg, 600 mg
Reference Brands: Zithromax, Z-Pak(US); Zidimax(EU)
Strength: 75 mg/2 mL
Form: Inhalation Solution (Nebulizer)
Reference Brands: Coly-Mycin M(US)
Strength: 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial
Form: Injectable (IV/IM/SC)
Strength: 3g in a sachet
Form: Oral Sachets or Powder for Suspension
Reference Brands: Zyflo(US)
Strength: 2 g, 4g per vial
Strength: 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL
Form: Injectable (IV/IM)
Reference Brands: Targocid, Tolocin(US & EU)
Strength: 500 mg, 1000 mg
Form: Tablet/Capsules
Reference Brands: Azulfidine(US); Salazopyrin(EU)
Strength: 80 mg/400 mg per 5 mL, 160 mg/800 mg per 5 mL
Reference Brands: Bactrim(US/India), Sulfatrim (EU)
Strength: 160 mg sulfamethoxazole + 800 mg trimethoprim; 80mg/400 mg
Form: Tablet
Reference Brands: Bactrim(US), Septra (India), Sulfatrim (EU)
Strength: 600 mg/2 mL, 1 g/2 mL, 2 g/2 mL
Reference Brands: Lincocin (US & EU)
Strength: 250mg, 500 mg
Form: Oral Capsules/Tablets
Reference Brands: Lincocin (US)
Strength: 75 mg/5 mL, 150 mg/5 mL, 300 mg/5 mL
Reference Brands: Cleocin(USA), Dalacin C(LATAM), Clindac (India)
Strength: 300 mg/2 mL, 600 mg/4 mL
Form: Injection (IV/IM)
Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
Strength: 1%, 2%
Form: Topical Creams and Ointments
Strength: 75 mg, 150 mg, 300 mg
Form: Oral Capsules
Reference Brands: Cleocin (USA), Dalacin C (EU/UK), Clindac (India)
Strength: 500 mg, 1 g per vial
Form: Injectable (IV)
Reference Brands: Doribax(US & EU)
Stay updated on pharma trends and marketplace opportunities.